Waldencast sets March 13, 2026 earnings release

Waldencast plc announced that it will release its Fourth Quarter and Fiscal Year 2025 earnings in a press release on March 13, 2026, before the U.S. market opens.

Rhea-AI Filing Summary

Waldencast plc announced that it will release its Fourth Quarter and Fiscal Year 2025 earnings in a press release on March 13, 2026, before the U.S. market opens. The company does not plan to host a conference call to discuss the results, citing its ongoing strategic review.

Waldencast is a global multi-brand beauty and wellness platform founded by Michel Brousset and Hind Sebti, built around developing, acquiring, and scaling conscious, high-growth, purpose-driven brands such as Obagi Medical and Milk Makeup.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Waldencast (WALD) report its Q4 and Fiscal Year 2025 earnings?

Waldencast will issue its Fourth Quarter and Fiscal Year 2025 earnings in a press release on March 13, 2026, before U.S. market open. The company disclosed this timing in a March 11, 2026 communication from its London headquarters.

Will Waldencast (WALD) hold an earnings conference call for Q4 and Fiscal Year 2025?

Waldencast does not plan to host a conference call to discuss its Fourth Quarter and Fiscal Year 2025 results. The company explained that this decision is related to its ongoing strategic review, and will instead communicate results solely through a press release.

What type of business is Waldencast (WALD) and what is its focus?

Waldencast is a global multi-brand beauty and wellness platform focused on conscious, high-growth, purpose-driven brands. Its model centers on developing, acquiring, accelerating, and scaling brands within beauty and wellness while maintaining each brand’s distinct identity and close connections to customers.

Which brands are currently part of the Waldencast (WALD) platform?

Waldencast’s first step in building its platform was a business combination with Obagi Medical and Milk Makeup. These brands are expected to benefit from the scale, expertise in managing global beauty brands, and the agile, asset-light operations of Waldencast’s multi-brand structure.

Who founded Waldencast (WALD) and what is their vision for the company?

Waldencast was founded by Michel Brousset and Hind Sebti. Their vision is to build a global best-in-class beauty and wellness operating platform that combines operational scale, brand-led agility, and market responsiveness while nurturing the unique DNA of each purpose-driven brand in the portfolio.

How does Waldencast (WALD) describe the benefits of its multi-brand platform?

Waldencast states its brands benefit from the operational scale of a multi-brand platform, expertise in managing global beauty brands, a balanced portfolio to mitigate category fluctuations, asset-light efficiency, and the responsiveness and speed typically associated with entrepreneurial indie beauty brands.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 04:16 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 or 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of: March 2026

Commission File Number: 001-40207

Waldencast plc

(Translation of Registrant’s name into English)

81 Fulham Road

London, SW3 6RD

United Kingdom

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

☒ Form 20-F ☐ Form 40-F

Information in this Report

The information in this report on Form 6-K (“Report”) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date

March 11, 2026 – London, United Kingdom – Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform announced that its Fourth Quarter and Fiscal Year 2025 earnings will be issued in a press release on March 13, 2026, prior to U.S. market open. The Company does not plan to host a conference call to discuss results given its ongoing strategic review.

About Waldencast plc

Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the business combination with Obagi Medical and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https://ir.waldencast.com/.

Contacts

Investors

ICR

Allison Malkin

waldencastir@icrinc.com

Media

ICR

Brittany Fraser

Waldencast@icrinc.com

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

						Waldencast plc
						(Registrant)
Date: March 11, 2026			By:			/s/ Manuel Manfredi
						Name:			Manuel Manfredi
						Title:			Chief Financial Officer and Principal Financial Officer

3